Reliq Health Technologies Inc. announced a private placement of up to 10,000,000 units at a price of CAD 0.40 per unit for gross proceeds of up to CAD 4,000,000 on a best efforts agency basis on September 27, 2023. Each unit will consist of one common share and one transferable share purchase warrant. Each warrant shall be exercisable into one additional common share of the company for a period of 30 months from the closing Date at an exercise price of CAD 0.52.

Upon closing of the offering, the company shall pay to PI Financial Corp. a cash commission equal to 8% of the aggregate gross proceeds of the offering and issue non-transferrable warrants of the company exercisable at any time prior to the date that is 30 months from the closing date to acquire that number of units equal to 8% of the number of units issued under the offering, at an exercise price equal to the warrant share price, subject to adjustment in certain events. The offering is scheduled to close on or around October 5, 2023 and is subject to certain conditions including, but not limited to, receipt of all necessary approvals including the approval of the TSX Venture Exchange.

The securities are not restricted to any hold period under applicable Canadian securities laws.